EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Defining Puberty and Spectrum of Hypogonadism in Alström Syndrome

Sadaf Ali iD, Qianwen Zhang, Ijeoma Anwunah, Shanat Baig, Gabriela da Silva Xavier, Charlotte Dawson, Francesca Dassie, Yijun Tang, Libo Wang, Guoying Chang, Paul Gleeson, Adrian T Warfield und 7 weitere

The Journal of Clinical Endocrinology & Metabolism · 18.12.2025 · 111 (1) · 33-44

DOI: 10.1210/clinem/dgaf356 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 13.06.2025. Verfasst von Sadaf Ali und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Inherited Metabolic Disorders, Queen Elizabeth Hospital Birmingham, Birmingham B15 2GW, UK. Hauptthemen laut MEDLINE: Hypogonadism, Alstrom Syndrome, Puberty. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Hospital Birmingham NHS Foundation Trust, National Nature Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Alström syndrome (AS) has been extensively studied for its multisystem organ manifestations. Primary gonadal failure is well described in humans, but little is known about the intricacies of puberty and true incidence of hypogonadism within this population.

Objective

We aimed to define the onset and progression of puberty and the incidence of hypogonadism in male patients with AS.

Methods

A retrospective, observational cohort study was conducted on patients with AS across the UK and Italy national services. Additionally, the findings were correlated with Alms1 S701X mouse model as part of the current study.

Results

We enrolled 28 pediatric patients (age 14.8 ± 2.3) and 41 adult patients (age 34 ± 12). All pediatric patients entered puberty at an appropriate age, but the highest testicular volume achieved by patients with AS was 9 ± 3 mL in age group of 14- to 15-year-old boys. Among adults, 95% (39/41) had hypogonadism with primary gonadal failure. Testicular analysis of the Alms1 S701X mouse model shows testicular atrophy with no evidence of fibrosis. Moreover, Alms1 S701X mice exhibit reduced sperm count and sperm motility compared with controls (29.03 × 106/mL vs 110.6 × 106/mL, 34.77% vs 70.18%).

Conclusion

Our study sheds light on the reproductive aspects of AS across pediatric and adult populations with particular emphasis on testicular and pubertal development, and hypogonadism in adult life. Although, all the pediatric patients with AS have age-appropriate onset of puberty, almost all exhibit hypogonadism with primary gonadal failure as adults. This mirrors the Alms1 S701X mouse model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypogonadismAlstrom SyndromePubertyHumansMaleAdolescentRetrospective StudiesAdultAnimalsMiceChildYoung AdultTestisDisease Models, AnimalItalyUnited KingdomCell Cycle Proteins

Stichwörter der Autor:innen

Alström syndromehypogonadismmale infertilityprimary testicular failurepubertyreproduction

Substanzen

ALMS1 protein, humanCell Cycle Proteins

Autor:innen und Institutionen

  • Department of Inherited Metabolic Disorders, Queen Elizabeth Hospital Birmingham, Birmingham B15 2GW, UK.
  • Institute of Metabolism and Systems Research, University of Birmingham, Birmingham B15 2TT, UK.
  • Department of Endocrinology and Metabolism, Shanghai Children's Medical Centre, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
  • Birmingham Women's and Children's Hospital, Birmingham B4 6NH, UK.
  • National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, Birmingham B15 2TH, UK.
  • Department of Medicine (DIMED), University of Padova, European Reference Network on Rare Endocrine Conditions (Endo-ERN), Azienda Ospedale-Università Padova, 35122 Padova, Italy.

ORCID-Profile: Sadaf Ali, Tarekegn Geberhiwot

Förderung

  • University Hospital Birmingham NHS Foundation Trust
  • National Nature Science Foundation of China
  • National Key Research and Development Program of China
  • Big Lottery Fund

Zitieren

APA

Ali, S., Zhang, Q., Anwunah, I., Baig, S., Xavier, G. D. S., Dawson, C., Dassie, F., Tang, Y., Wang, L., Chang, G., Gleeson, P., Warfield, A. T., Paisey, R., Barrett, T. G., Maffei, P., Wang, X., Homer, V., Kershaw, M., & Geberhiwot, T. (2025). Defining Puberty and Spectrum of Hypogonadism in Alström Syndrome. The Journal of Clinical Endocrinology & Metabolism, 111(1), 33-44. https://doi.org/10.1210/clinem/dgaf356

Vancouver

Ali S, Zhang Q, Anwunah I, Baig S, Xavier GDS, Dawson C, et al. Defining Puberty and Spectrum of Hypogonadism in Alström Syndrome. The Journal of Clinical Endocrinology & Metabolism. 2025;111(1):33-44. doi:10.1210/clinem/dgaf356

BibTeX
@article{Ali2025,
  author = {Ali, Sadaf and Zhang, Qianwen and Anwunah, Ijeoma and Baig, Shanat and Xavier, Gabriela da Silva and Dawson, Charlotte and Dassie, Francesca and Tang, Yijun and Wang, Libo and Chang, Guoying and Gleeson, Paul and Warfield, Adrian T and Paisey, Richard and Barrett, Timothy G and Maffei, Pietro and Wang, Xiumin and Homer, Victoria and Kershaw, Melanie and Geberhiwot, Tarekegn},
  title = {Defining Puberty and Spectrum of Hypogonadism in Alström Syndrome},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {111},
  number = {1},
  pages = {33--44},
  doi = {10.1210/clinem/dgaf356}
}
Kostenlos starten →